March 3, 2016
Evonik begins basic engineering for 2nd methionine plant in Singapore
Evonik Industries has started basic engineering for the construction of a second production plant for the amino acid DL-methionine in Singapore.
The plant complex, with a projected annual production capacity of 150,000 tonnes, is expected to come on stream in 2019.
The decision is based on the continuing increase in the demand for sustainable animal nutrition. "We have supported the strong market growth of DL-methionine over the years by timely and needs-driven expansion of our production capacities, and we plan to continue doing this," says Klaus Engel, chairman of the executive board of Evonik.
The specialty chemicals group markets DL-methionine under the MetAMINO® brand name.
The new complex will be erected next to Evonik's existing methionine plant on Jurong Island, Singapore, which was commissioned in late 2014. "Like our first methionine plant in Singapore, which went on stream on schedule, this project too is progressing according to plan," points out Reiner Beste, chairman of the board of the management of Evonik Nutrition & Care GmbH.
Singapore was once again selected as the site because Evonik can service the Asian growth market particularly well from there. In the new, fully backward-integrated production complex, Evonik will produce all strategically important precursors itself. "This guarantees high product quality as well as supply security," explains Beste.
Evonik first made an official announcement of the new plant last year: /contents/10-01-2015/6679db50-aa2a-485e-92c9-b164ee39ba8b-a181.html
